The Supplement of Magnesium Element to Inhibit Colorectal Tumor Cells

Biol Trace Elem Res. 2023 Jun;201(6):2895-2903. doi: 10.1007/s12011-022-03393-2. Epub 2022 Aug 25.

Abstract

Magnesium ions are essential elements to the human body, with a daily intake of about 350 mg for an adult. Recently, a meta-analysis reported that magnesium ion intake is related to a reduced risk of colorectal tumors. In addition, implantation of biodegradable magnesium pins after colorectal tumor resection could potentially inhibit the residual tumor cells. These impressive results implied that magnesium ions possess inhibitory properties against colorectal carcinoma. However, this hypothesis has yet to be confirmed by experimental results. In this work, different concentrations of magnesium ions were modulated to investigate their inhibitory effects on cell viability through cell cycle arrest, subsequently inducing apoptosis by activating the caspase-3 pathway. The animal experiments revealed that magnesium injection restricted tumor growth after 3 weeks of treatment compared to the control group. According to the immunohistochemistry and transmission electron microscopy results, the remarkable effect may be attributed to promoting the apoptotic rate of tumor cells. The evidence highlights the potential for the clinical use of magnesium implants to inhibit the growth of residual cells after colorectal tumor surgery.

Keywords: Colorectal tumor; In vitro; In vivo; Magnesium ions; Tumor inhibition.

MeSH terms

  • Animals
  • Apoptosis
  • Cell Cycle Checkpoints
  • Cell Proliferation
  • Colorectal Neoplasms* / pathology
  • Humans
  • Ions
  • Magnesium* / pharmacology
  • Magnesium* / therapeutic use

Substances

  • Ions
  • Magnesium